The U.S. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, the Institute for Clinical and Economic Review, an influential drug pricing body, said in a report Thursday.
House Bipartisan Group Targets Sex Misconduct Claims
Maggio 14, 2026
The House’s top Republican and Democrat, usually at odds on policy matters, have come together to form a bipartisan initiative to address sexual misconduct claims
